Interview with Derek Cunningham, OD
Steroids plays an integral role in the treatment of dry eye disease for acute and chronic inflammation. Although steroids have been used off-label for many years to address inflammation, the question remains is does on-label or off-label indication matter? In this episode, Derek Cunningham, OD, FAAO shares his thought on the subject and how he utilizes steroids in clinical practice.
As a global specialized company dedicated to ophthalmology, Santen brings a 130-year history of scientific knowledge and organizational capabilities to research, development, and commercialization of pharmaceuticals, surgical and medical devices, and OTC eye-care products. Santen is the market leader for prescription ophthalmic pharmaceuticals in Japan, and its products now reach patients in more than 60 countries. Santen provides products and services to contribute to the well-being of patients, their loved ones, and consequently to society. For more information, please visit Santen’s websites www.santenusa.com and www.santen.com (Japan headquarters).
Interview with Derek Cunningham, OD
Steroids plays an integral role in the treatment of dry eye disease for acute and chronic inflammation. Although steroids have been used off-label for many years to address inflammation, the question remains is does on-label or off-label indication matter? In this episode, Derek Cunningham, OD, FAAO shares his thought on the subject and how he utilizes steroids in clinical practice.
